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Abstract 32 
Emergence of viruses into the human population by transmission from non-human primates 33 
(NHPs) represents a serious potential threat to human health that is primarily associated with 34 
the increased bushmeat trade. Transmission of RNA viruses across primate species appears to 35 
be relatively frequent. In contrast, DNA viruses appear to be largely host specific, suggesting low 36 
transmission potential. Herein, we use a primate predator-prey system to study the risk of 37 
herpesvirus transmission between different primate species in the wild. The system was 38 
comprised of Western chimpanzees (Pan troglodytes verus), and their primary (Western Red 39 
Colobus; Piliocolobus badius badius) and secondary prey (Black-and-white Colobus; Colobus 40 
polykomos) monkey species. NHP species were frequently observed to be co-infected with 41 
multiple beta- and gammaherpesviruses (including new cytomegalovirus and rhadinovirus 42 
species). However, despite frequent exposure of chimpanzees to blood, organs and bones of 43 
their herpesvirus-infected monkey prey, there was no evidence for cross-species herpesvirus 44 
transmission. These findings suggest that interspecies transmission of NHP beta- and 45 





INTRODUCTION  48 
Zoonotic transmission of animal pathogens into the human population is regarded as the major 49 
source of new human infectious disease (1-3). Such zoonoses have profoundly altered the 50 
course of human history, as reflected by the impact of the bubonic plague, Spanish flu and 51 
HIV/AIDS on human society (4-6). Zoonoses are frequently transmitted to humans following an 52 
initial cross-species transmission into an intermediate animal host. Mechanisms underlying 53 
cross-species transmission and adaptation to new host species are far from clear, but appear to 54 
be influenced by multiple factors, including: the level and mode of interaction between animal 55 
reservoir/transmission source and humans, the phylogenetic relationship of these species, and 56 
the nature of the zoonotic pathogen (2, 7, 8). Zoonotic/enzootic cross-species transmission 57 
appears to be a relatively common characteristic of RNA viruses (8). In contrast, the efficiency of 58 
cross-species transmission for DNA viruses is unclear. For the Herpesviridae family, transmission 59 
appears to be a relatively rare event. In the few instances where virus transmission has been 60 
observed, the lack of onward transmission and uncharacteristically highly pathogenic 61 
presentation of overt disease in the new species (eg., ovine/caprine herpesvirus infection in 62 
free-ranging cervids; and herpesvirus B in humans) suggest that herpesviruses poorly adapt to 63 
their new host environment (9-11). 64 
 To date, most studies examining cross-species transmission of herpesviruses have been 65 
based on phylogenetic analysis of genomic sequences. These studies reveal well-defined 66 
genotypic groupings within each of the three virus subfamilies (alpha, beta and gamma) (12). 67 
This phylogenetic distribution has been interpreted as co-evolution (co-divergence) of the major 68 




species transmission. More recent sensitive methods of analysis using degenerate PCR targeting 70 
common conserved regions of the herpesvirus genome support co-divergence as the prominent 71 
mode of evolution of this virus family (13-15). However, these studies also reveal the presence 72 
of repeated cross-species beta- and gammaherpesvirus transmission over evolutionary time. 73 
Epstein-Barr virus (EBV) and a group of closely related African hominid gammaherpesviruses 74 
(genus Lymphocryptovirus; LCV) were shown to be derived from at least two independent 75 
introductions from Old World monkey (OWM) LCVs within the past 12 million years (14). 76 
Similarly, transmission of betaherpesviruses (cytomegalovirus; CMV) was observed between 77 
chimpanzees and gorillas, but the frequency of transmission, and whether transmission had 78 
occurred within recent or historic time (within the last million years) could not be determined 79 
(15).  80 
In the present study, we use several sensitive, degenerate primer-based PCR assays for 81 
the detection of herpesviruses of different genera, in combination with phylogenetic analysis  82 
and specific PCR, to study cross-species beta- and gammaherpesvirus transmission in a large 83 
natural primate ecosystem in the Taï National Park, Côte d’Ivoire (Western Africa). The study 84 
population is comprised of a great ape predator species (Western chimpanzee; Pan troglodytes 85 
verus), and its primary (Western Red Colobus, WRC; Piliocolobus badius) and secondary (Black-86 
and-white Colobus, BWC; Colobus polykomos) monkey prey, for which interspecies transmission 87 
of various retroviruses has been shown (16, 17). Our study shows that each primate species is 88 
infected with multiple species-specific beta- and gammaherpesviruses, but we find no evidence 89 
for cross-species transmission and persistence of these viruses between the interacting ape and 90 
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MATERIALS AND METHODS 93 
Sample collection and DNA isolation. Necropsy samples were collected from 23 chimpanzees 94 
(Pan troglodytes verus) (bladder, bone, brain, buffy coat, heart, heart blood, intestine, kidney, 95 
liver, lung, lymph node, nasal swab, oral swab, pancreas, plasma, serum, spleen, thymus, tonsil, 96 
trachea and whole blood; n=99); from 11 WRC (buffy coat, heart, kidney, liver, lung, lymph 97 
node, spleen, and trachea; n=40); and from 11 BWC (buffy coat, liver, spleen, and trachea; 98 
n=12) – all originating from the same area of the Taï National Park in Côte d’Ivoire. Cause of 99 
death for the chimpanzees were anthrax (34), respiratory diseases (30), or undetermined (35), 100 
and occurred between 2001 and 2009. The WRC and BWC were collected in the same time 101 
period. For all samples originating from Côte d’Ivoire, sample collection was performed using 102 
full body protection suits and masks due to a history of Ebola and Anthrax in these populations 103 
and to avoid any contamination of samples with human pathogens. Permission for sample 104 
collection from wild primates was obtained from the relevant authorities, and tissue samples 105 
were exported with the appropriate CITES authorization from Côte d’Ivoire to Germany. 106 
Sample importation adhered to German veterinary regulations for importation of organic 107 
materials. All samples were preserved in liquid nitrogen upon arrival at the research camps and 108 
were later transferred to -80°C at the Robert Koch-Institute. DNA was isolated using the DNeasy 109 
Tissue Kit (Qiagen, Hilden, Germany).  110 
 111 
Herpesvirus PCR. Details of the PCR are given below. Following PCR, all PCR products were 112 




terminator cycle sequencing kit (Applied Biosystems, Warrington, UK) in a 377 DNA automated 114 
sequencer (Applied Biosystems). 115 
(i) Generic CMV PCR (PCR 1 and PCR 2). For generic detection of glycoprotein B (gB; 116 
ORF UL55 in HCMV) and UL56 genes of members of the genus Cytomegalovirus only, gB 117 
(PCR 1) and UL56 (PCR 2), nucleic acid sequences were amplified with nested sets of 118 
degenerate primers (Table S1) derived from the gB gene and the UL56 gene of HCMV 119 
(strain AD169; accession no. NC_001347). The primer sites were located in regions 120 
conserved among the betaherpesviruses. The primers were only moderately degenerate 121 
in order to avoid amplification of roseoloviruses, alpha- and gammaherpesviruses. PCR 122 
was performed at an annealing temperature of 45oC under conditions used in PCR5 123 
(generic DPOL PCR) [below and as previously described (18)]. 124 
(ii) Long-distance (LD) PCR for amplification of WRC CMV gB sequences (PCR 3). 125 
Nested non-degenerate primers (Table S1) were designed using the sequences identified 126 
with PCR 1 and 2. Nested LD PCR of the near complete gB gene (approximately 2.2 kb) of 127 
the novel WRC CMVs was then performed using the TaKaRa-Ex PCR system according to 128 
the manufacturer’s instructions (Takara Bio Inc., Japan). 129 
(iii) Diagnostic PCR for amplification of WRC CMV gB sequences (PCR 4). For 130 
differential amplification of novel WRC CMVs, 2 specific non-degenerate primer pairs 131 
(Table S1) were designed following alignment of the 2.2 kb gB sequences obtained from 132 
the WRC CMVs. These primers were used in a nested format under the same PCR 133 
conditions as in PCR 5, except that AmpliTaq Gold was used at 0.2 μl / 25 μl reaction 134 




sec, 58oC for 30 sec, and 72oC for 1 min, followed by a 10 min final extension step at 72oC. 136 
(PCR 4). 137 
(iv) Generic herpesvirus PCR (PCR 5). For generic detection of members of the genus 138 
Lymphocryptovirus, sequences of the herpesvirus DNA polymerase (DPOL) gene (UL30 in 139 
HSV1; UL54 in HCMV; BALF5 in EBV; ORF9 in HHV-8) were amplified with a nested set of 140 
degenerate primers (Table S1) as described previously (18). 141 
(v) Diagnostic PCR for amplification of WRC LCV DPOL sequences (PCR 6). For the 142 
detection of all novel WRC LCVs, specific primers (Table S1) were designed following 143 
alignment of the WRC LCV DPOL sequences identified with PCR 5. Amplification was 144 
performed under the PCR conditions of PCR 4, except that annealing was at 62 oC (PCR 6). 145 
(vi) Generic RHV PCR (PCR 7). For generic detection of members of the genus 146 
Rhadinovirus, gB nucleic acid sequences were amplified with a nested set of degenerate 147 
primers (Table S1) as described previously (13). 148 
(vii) Diagnostic PCR for amplification of WRC and BWC gB sequences (PCR 8). For the 149 
differential detection of all novel WRC and BWC RHVs, specific primers (Table S1) were 150 
deduced from an alignment of the identified DPOL sequences of WRC and BWC RHVs 151 
identified with PCR 7. They were used under the PCR conditions of PCR 4, except that 152 
annealing was at 62oC (PCR 8).  153 
 154 
Phylogenetic analysis. Sets of nucleic acid sequences were aligned using the MAFFT [Katoh et 155 
al., 2002] plug-in of the software Geneious Pro v.5.5.7. Alignments were trimmed before using 156 




alignable and of loci with a gapping character in any sequence. Phylogenetic analysis was 158 
performed with the Neighbor-Joining module of Geneious Pro. 159 
 160 
RESULTS  161 
Detection of cytomegaloviruses in chimpanzees and colobus monkeys 162 
A core set of 130 nonhuman primate (NHP) samples in total were available for PCR-based 163 
analysis. The samples consisted of tissue and blood, and nasal/oral swabs from live or deceased 164 
members of the 3 primate species of the study. Samples were tested for the presence of CMVs 165 
by using generic primers that detect CMVs (with the exception of roseoloviruses), alpha- and 166 
gammaherpesviruses (PCR 1; Table S1). Bands of the expected product size were purified and 167 
sequenced. Fifteen of 79 (19%) chimpanzee samples, corresponding to 6 of 23 individuals (26%) 168 
(Table 1), were positive for CMV (PtroCMV) (Table 2). The highest percentage (31%) was found 169 
in the lungs of deceased individuals (Table 2). The identified sequences originated from the 170 
known chimpanzee CMVs PtroCMV1, PtroCMV2 and CCMV (Table 3; Table S2) (15). A number of 171 
animals were shown to be infected with multiple CMVs (Table 4). 172 
Eleven of 39 (28%) of WRC samples tested positive for CMV with the generic CMV PCR (PCR 173 
1, Table S1), corresponding to 6 of 11 (54%) of animals (Table 1), with a majority of the positive 174 
samples being lung and spleen samples (64%) (Table 2). Two of 12 (17%) BWC samples, both 175 
derived from a single animal (Table 1), were PCR-positive for CMV (Table 2). Sequences of the 176 
13 colobus-derived CMV PCR products were subjected to BLAST analysis, and determined to 177 
originate from 4 formerly unknown CMV species (3 from WRC and 1 from BWC). These novel 178 




showed the presence of multiple CMVs (Table 4). The analysis also confirmed the absence of 180 
chimpanzee CMV in any of the monkey samples. 181 
A phylogenetic tree was constructed using a MAFFT alignment of sequences from human 182 
CMV (HCMV) (strains Toledo and AD169), great ape CMVs (chimpanzee and gorilla) and OWM 183 
CMVs (African green monkey, mandrill, rhesus macaque and multiple colobus monkey species). 184 
Inspection of the tree revealed the presence of two distinct clades: one clade was comprised of 185 
human and great ape CMVs, and the other clade of OWM CMVs. In the OWM clade, the novel 186 
WRC CMVs (PbadCMV1, PbadCMV1b, PbadCMV2) formed a distinct subclade together with a 187 
WRC CMV (designated PbadCMV3) that we had detected previously in spleens of 2 WRC (B. 188 
Ehlers, unpublished). The novel BWC CMV (CpolCMV1) was closely related to the colobus 189 
guereza virus, CgueCMV1.2 (Figure 1a).  190 
WRC are the major monkey prey species of chimpanzees in the Taï National Park. To assess 191 
whether CMVs of WRC were present in chimpanzees, we used nested PCR primers that were 192 
designed to specifically target WRC CMVs without amplifying of chimpanzee CMV. Since the gB 193 
sequences of the novel WRC CMVs were too short for design of the necessary primers, the UL56 194 
3’-region of 3 of the WRC CMVs (PbadCMV1, PbadCMV1b and PbadCMV2) was amplified by 195 
generic UL56 PCR (PCR 2; Table S1), followed by amplification of a 2.2kbp region between gB 196 
(UL55) and UL56 by using long-distance PCR (PCR 3; Table S1). This 2.2kbp section of PbadCMV 197 
sequence was then used for primer design (PCR 4; Table S1). Analysis using PCR 4 did not detect 198 





Detection of lymphocryptoviruses in chimpanzees and colobus monkeys 201 
A generic herpesvirus PCR targeting the highly conserved DNA polymerase gene (DPOL) (PCR 5; 202 
Table S1) was used to analyze 39 chimpanzee samples for the presence of lymphocryptoviruses 203 
(LCV; subfamily Gammaherpesvirinae). Lung, spleen and lymph node samples were selected for 204 
analysis, since they had been shown to be prominent sources of gammaherpesviruses in 205 
previous studies (13, 14, 19). Sequencing of the amplified products showed 13 of 31 samples 206 
(42%) to be positive for LCV (Table 2). All sequences originated from an LCV that had 99% 207 
identity with PtroLCV1, an LCV previously identified in chimpanzees (Table 3; Table S2) (19). 208 
Spleens and lymph nodes of deceased chimpanzees showed the highest level of LCV positivity 209 
(55% and 57%, respectively). WRC (17 samples) and BWC (10 samples; including buffy coat) 210 
were analysed for the presence of LCV (PCR 5; Table S1). Five of 22 monkeys (23%) (4 WRC and 211 
1 BWC) were positive for OWM LCV (Table 1). This was represented by six of 17 (35%) WRC 212 
samples (all from the lung and spleen), and 1 of 10 BWC samples (from buffy coat) testing 213 
positive for LCV (Table 2). BLAST analysis identified a previously reported WRC LCV (PbadLCV1) 214 
(14), and a novel BWC LCV (designated as CpolLCV1). This PCR analysis also confirmed the 215 
absence of chimpanzee LCV in the animals. 216 
Phylogenetic analysis was performed using the corresponding DPOL region of LCV sequences 217 
from human (Epstein Barr Virus; EBV), great ape (chimpanzee and gorilla) and OWM (colobus 218 
guereza and rhesus macaque) viruses. In the tree (Figure 1b), WRC LCV (PbadLCV1 and the 219 
previously identified PbadLCV2) formed a clade distinct from a mixed clade comprising human, 220 




were selected to test for the presence of WRC LCV in chimpanzees (PCR no. 6; Table S1). This 222 
PCR did not detect WRC LCV in any chimpanzee sample (not shown). 223 
 224 
Detection of rhadinoviruses in chimpanzees and colobus monkeys 225 
Gammaherpesvirus-specific gB PCR (PCR 7; Table S1) was used to analyze the 31 lung, spleen 226 
and lymph node chimpanzee samples for the presence of rhadinoviruses (RHV; subfamily 227 
Gammaherpesvirinae). Six of 31 samples (19%) were positive for RHV (Table 2), and the 228 
detected virus was identical to the previously identified PtroRHV2 (Table 3; Table S2) (27). 229 
Similar to the distribution of CMV, lungs of deceased chimpanzees showed a high level of RHV 230 
positivity (20%). All chimpanzee samples were also tested by using the generic DPOL PCR (PCR 5; 231 
Table S1), which resulted in detection of the known PtroRHV1 (Table 3; Table S2) (27). Similar to 232 
CMV, one animal showed the presence of multiple RHV viruses (Table 4).  233 
In the final analysis, the 17 WRC and 10 BWC samples were tested for the presence of RHV 234 
with PCR 7. Seven of 22 (32%) monkeys (2 WRC and 5 BWC) were positive for OWM RHV (Table 235 
1). Two of 17 WRC samples (12%) and 6 of 10 BWC samples (60%) were RHV PCR-positive, with 236 
viruses being distributed between lymphoid organs (spleen and lymph nodes), liver and blood 237 
(buffy coat) (Table 2). BLAST analysis identified the presence of two novel viruses (designated 238 
PbadRHV1 and CpolRHV1) and confirmed the absence of any chimpanzee RHV in the monkeys. 239 
All WRC and BWC samples were also tested by using the generic DPOL PCR (PCR 5; Table S1), 240 
with the same RHVs being detected (data not shown). 241 
Phylogenetic analysis was performed using published gB sequences from human herpesvirus 242 




pig-tailed macaque). Distinct clades of great ape RHV and OWM RHV were apparent (Figure 1c). 244 
The presence of a distinct clade containing WRC, BWC and rhesus RHV, enabled the design of 245 
clade-specific primers that detected colobus RHV, but excluded great ape RHV (PCR 8; Table S1). 246 
Use of these primers confirmed the absence of colobus RHV in all chimpanzee samples (data not 247 
shown). 248 
 249 
Summary of DNA viruses detected and novel viruses discovered 250 
In the present study, we detected 4 novel OWM CMVs (PbadCMV1, PbadCMV1b, PbadCMV2 251 
and CpolCMV1), 1 novel OWM LCV (CpolLCV1) and 2 novel OWM RHVs (CpolLCV1 and 252 
PbadRHV1) in the colobus monkey study group. Together with previously identified 253 
herpesviruses detected in this study, the novel viruses are listed in Table 3 and are presented 254 
phylogenetically in Figure 1. The detection frequency of herpesviruses in individual chimpanzees 255 
was 26% (CMV), 45% (LCV) and 18% (RHV); in WRC 55% (CMV), 36% (LCV) and 18% (RHV); and in 256 
BWC 9% (CMV), 9% (LCV) and 45% (RHV) (Table 1). Individual chimpanzees and monkeys were 257 
shown to be infected by multiple herpesviruses, but with no apparent bias towards co-infection 258 
with particular viruses (Table 4). Finally, although all primate species were infected to a 259 
substantial level with their own species-specific beta- and gammaherpesviruses, there was no 260 
evidence for cross-species transmission.  261 
 262 
DISCUSSION 263 
We have used highly sensitive degenerate PCR in combination with specific PCR and 264 




in a great ape predator (Western chimpanzee), and its primary (WRC) and secondary (BWC) 266 
monkey prey species. Our results show that all three primate species are commonly infected 267 
(and frequently co-infected) with multiple species-specific CMV, LCV and RHV herpesviruses. 268 
The lung and spleen of WRC and BWC monkeys were observed to be the most frequent sites of 269 
herpesvirus infection. Seven of the herpesviruses detected in this study represent new viruses 270 
described for the first time.  271 
Hunting frequently involves biting (both of monkeys by chimpanzees, and on occasion, of 272 
chimpanzees by monkeys). Most monkey tissues, organs and bone marrow are consumed in 273 
their entirety by chimpanzees. Marrow is extracted by crushing of bones, which furthers the 274 
possibility for direct blood-to-blood contact by oral laceration. This predator-prey system, in 275 
which chimpanzees are exposed on a continual basis to monkey blood and tissues, therefore 276 
represents a unique natural primate ecosystem in which to assess microbe cross-species 277 
transmission in the wild. This intensive level of interaction has been shown to lead to 278 
transmission of retroviruses such as STLV-1 and SFV between chimpanzees and monkeys (16, 279 
17, 20, 21). However, despite this extensive exposure, there was no evidence for cross-species 280 
transmission of herpesviruses between these species. 281 
Following primary infection, herpesviruses establish life-long infection within their 282 
respective host species (22). Our PCR-based analysis is therefore both a measure of cross-283 
species herpesvirus transmission, and the ability of transmitted viruses to establish themselves 284 
within the new host. Excluding the period of acute infection, this method of analysis will only 285 
detect cross-species transmission if the virus persists following transmission, thereby avoiding 286 




serological-based approaches). Beta- and gammaherpesviruses are phylogenetically closely 288 
grouped into distinct clades based on the specific primate species they infect. Our phylogenetic 289 
analysis is therefore able to detect persistence of transmitted herpesviruses not only in 290 
contemporary time, but also at the population level extending over the past 20 million years 291 
(assuming an ability of transmitted viruses to be maintained within the new host species 292 
population; see below). By both measures, cross-species transmission/persistence of beta- and 293 
gammaherpesviruses was not detected between the different primate study populations.    294 
The considerable level of interaction between prey and predator species in the primate 295 
ecosystem studied here, combined with the high prevalence of herpesviruses within the two 296 
species, would be expected to promote the possibility for transmission, such that exposure to 297 
herpesviruses would not be the limiting factor. The absence of transmission more likely reflects 298 
the inability of herpesviruses to genetically adapt to a level sufficient to infect and then persist 299 
within the new primate host. Following exposure, a microbe must be able to persist and spread 300 
within the new population, represented by the basic reproduction number R0 (new infections 301 
per unit time). R0 is a critical measure of the potential for success of the pathogen within its new 302 
host population, with only R0 values > 1 being generally consistent with maintenance of an 303 
enzootic/zoonotic cross-species transmission (8). Given the predator-prey nature of the 304 
relationship, the possibility for transmission of microbes from chimpanzees into the monkey 305 
population would be limited. However, the calculation that the average adult male chimpanzee 306 
in the Taï National Forest consumes nearly 250 kilograms of colobus meat during their twenty 307 
year lifetime suggests extensive exposure of chimpanzees to herpesvirus-infected monkey 308 




that primate herpesviruses maintain a high degree of species-specificity, even between related 310 
primate species. It is possible that within the limits imposed by our animal group size of 24 311 
chimpanzees we were unable to observe transmission/persistence events that were occurring 312 
at a low frequency. Our results therefore do not rule out the possibility for herpesvirus 313 
transmission between these interacting primate populations, but indicate that transmission is, 314 
in the least, rare.   315 
The level of genetic similarity between reservoir/transmission species and new host has 316 
been suggested to play an important role in facilitating enzootic/zoonotic cross-species 317 
transmission by weakening the ‘species barrier’, and thereby potentially increasing both I0 (the 318 
number of primary infections) and R0. This effect of host phylogenetic similarity on transmission 319 
is reflected in the high incidence of tropical zoonotic diseases that have a non-human primates 320 
(NHP) source (2, 24-26). Genetic similarity between these primate species is thought to facilitate 321 
pre-adaptation or rapid adaptation of the microbe, promoting its transmission and 322 
establishment within humans; this can be compared to the relative inefficiency of microbes 323 
moving to humans from more distantly related animal species (i.e., H5N1 avian flu from birds). 324 
In the system studied here, even the presumed weak species barrier resulting from the close 325 
phylogenetic relationship between the chimpanzees and their interacting monkey species 326 
appears to be sufficient to prevent herpesviruses from transmitting and persisting within a new 327 
primate host species. 328 
RNA viruses appear to be particularly prone towards cross-species epizootic/zoonotic 329 
transmission (8, 27). This propensity of RNA viruses for cross-species transmission is believed to 330 




adaptation to the new host environment (8, 27). In contrast, replication of DNA viruses such as 332 
herpesviruses is characterized by low level ‘smouldering’ or ‘latent’ infection with periodic 333 
reactivation (increased levels of herpesvirus replication and overt disease during the chronic 334 
phase of infection are generally seen only associated with immunosuppression). DNA viruses 335 
also have far higher fidelity of replication than observed for RNA viruses (27). Both of these 336 
factors may result in reducing the potential for adaptation of herpesviruses to a new host, 337 
negatively impacting I0 and R0, and reducing capacity for cross-species epizootic/zoonotic 338 
transmission. 339 
 Our current study would suggest that relatively strict species specificity exists for primate 340 
beta- and gammaherpesviruses. Previous results from in vitro studies are consistent with our 341 
findings, with species-specific CMVs replicating poorly in cells from other species (28-30). In 342 
these studies, the genetic similarity between host species appeared to influence the replicative 343 
capacity of the respective CMVs, with HCMV replication being reduced only 10-fold in 344 
chimpanzee cells, compared to being non-detectable in cells from mice. In vivo studies support 345 
this level of species specificity, with no cross-species transmission/persistence being observed 346 
for murine CMV (MCMV) from naturally infected M. domesticus (house mouse) to native L. 347 
lakedownensis (short-tailed mice) following the release of MCMV-infected house mice into the 348 
Thevenard Island natural reserve (31). In the Thevenard Island study, MCMV did not replicate 349 
even following direct inoculation of virus into L. lakedownensis.  350 
The capacity for transmission of gammaherpesviruses has not been empirically examined. 351 
However, degenerate PCR-based approaches, similar to those used in the present study, 352 




gammaherpesviruses at least on an evolutionary time-scale – although the scarcity of these 354 
events would support that such transmission is rare. Specifically, phylogenetic analysis provides 355 
evidence for transmission of CMV between ape species (chimpanzees and gorillas) within the 356 
last million years, and of at least two independent introductions of OWM LCV into ape 357 
populations around 12 million years ago (14, 15). An OWM LCV transmission into Asian apes 358 
(orang-utans and gibbons) is also believed to have occurred more recently, approximately 1 359 
million years ago (14). There is also evidence for transmission of non-primate herpesviruses 360 
(specifically, RHVs) (13). Interestingly, the close phylogenetic relationship of RHVs from spotted 361 
hyena with those of zebra/horses, and of lion RHV with those of wild pig/rhino species, suggest 362 
that a predator and prey interaction may be one scenario that favours cross-species herpesvirus 363 
transmission. Together with results from these earlier studies, the lack of evidence for 364 
transmission/persistence of primate beta- and gammaherpesviruses in our current study 365 
suggests that although viruses from these two herpesvirus families are capable of cross-species 366 
transmission/persistence, such events are rare on both a contemporary and evolutionary time-367 
scale.   368 
Due to high immunogenicity and ‘effector’ T cell memory bias of CMV-induced immune 369 
responses, a number of laboratories are developing CMV as a vaccine platform (32-36). CMVs 370 
have evolved to spread through their target host population, and have a remarkable capacity to 371 
reinfect the host regardless of prior CMV immunity (37). We and others are therefore beginning 372 
to exploit this ability of CMV to spread for the development of ‘disseminating’ vaccines to target 373 
animal populations that are geographically or economically inaccessible to standard vaccination 374 




immunocontraception in mice to prevent mouse plagues) (33, 35). The present study furthers 376 
our understanding of the capacity for cross-species transmission of CMV between closely 377 
related species in a natural ecosystem, which will be critical as these vaccine strategies move 378 
towards potential application. 379 
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Figure 1.  Phylogenetic analysis. Partial gene sequences from the herpesviruses detected in this 496 
study and from published herpesviruses were aligned using MAFFT and subjected to 497 
phylogenetic construction of trees using the Geneious 5.5.7 tree builder (Neighbor-Joining 498 
module). Human, great ape and OWM herpesviruses are in red, green and blue font, 499 
respectively. Viruses detected in this study are marked (black dot). (A) tree based on 500 
glycoprotein B sequences of CMVs; (B) tree based on DNA polymerase sequences of LCVs; (C) 501 
tree based on glycoprotein B sequences of RHVs. Bootstrap values are indicated at the basis of 502 










Cytomegaloviruses 23 (6) a 11 (6) 11(1) 
Lymphocryptoviruses 22 (10) 11 (4) 11(1) 
Rhadinoviruses 22 (4) 11 (2) 11(5) 
 510 
a number of individuals tested (number of individuals positive in generic PCR) 511 
 512 




Table 2   Organs of NHP positive in generic PCR 514 
 515 
 Chimpanzee WRC BWC 
Cytomegaloviruses    
Lung 16 (5)a 8 (4) - 
Spleen 7 (1) 7 (3) 1 (1) 
Liver 10 (2) 7 (2) 1 (1) 
Heart 5 (1) 2 (1) - 
Lymph node 11 (1) 2 - 
Intestine 12 -  
Tonsil 6 (2) - - 
Kidney 3 2 (1) - 
Whole blood 4 (1) - - 
Thymus 1 (1) - - 
Pancreas 1 (1) - - 
Brain 2 - - 
Bladder 1 2 - 
Trachea - - 1 
Blood (buffy coat) - 8 9 
Heart blood - 1 - 
Sum 79 (15) 39 (11) 12 (2) 
    
Lymphocryptoviruses    
Lung 15 (4) 8 (3) - 
Spleen 7 (4) 7 (3) 1 
Lymph node 9 (5) 2 - 
Liver n.d. n.d. 1 
Trachea - - 1 
Blood (buffy coat) - n.d. 7 (1) 
Sum 31 (13) 17 (6) 10 (1) 
    
Rhadinoviruses    
Lung 15 (3) 8 - 
Spleen 7 (1) 7 (1) 1 (1) 
Lymph node 9 (2) 2 (1) - 
Liver n.d. n.d. 1 (1) 
Trachea - - 1 
Blood (buffy coat) - n.d. 7 (4) 
Sum 31 (6) 17 (2) 10(6) 
 516 
 a number of samples (number of samples PCR-positive in generic PCR) 517 
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